CADTH, through the pCODR program, systematically monitors the cancer drug pipeline — cancer drugs currently under development. CADTH diligently tracks drugs in the pipeline to:
- identify new cancer drugs and existing cancer drugs proposed for new indications
- gain awareness of emerging trends in oncology treatment
- assist provincial drug programs, cancer agencies, and CADTH with proactive health system planning and program operations.
As part of our commitment to transparency, CADTH shares these aggregate results on our website.